Cover Image

Effectiveness of Ozone Therapy on rapid radiologic and clinical recovery of a patient diagnosed with COVID-19.


Abstract


SARS-CoV-2 is an RNA virus that can cause pneumonia leading to acute respiratory distress syndrome and pulmonary fibrosis (PF). Lung damage caused by COVID-19 can cause severe permanent respiratory failure. Ozone therapy (OT) is used as a complementary treatment during the COVID-19 pandemic. PF, which is one of the interstitial lung diseases, is also radiologically identified in COVID-19 patients. In this case report, regression and healing on thorax CT findings are presented for a severe COVID-19 pneumonia-related intensive care unit patient who was diagnosed with PF on the post-COVID ward and treated with OT on the ward and even after discharge from hospital.

Keywords


COVID-19, Pulmonary fibrosis (PF), Ozone therapy, Antiviral

Full Text:

PDF

References


  1. Conti P, Gallenga CE, Tete G, Caraffa A, Ronconi G, Younes A, Toniato E, Ross R, Kritas SK. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. J Biol Regul Homeost Agents. 2020;34(2):333-338.

  2. Li H, Du S, Yang L, et al. Rapid pulmonary fibrosis induced by acute lung injury via a lipopolysaccharide three-hit regimen. Innate Immun. 2009; 15(3):143-54.

  3. Hernandez A, Papadakos PJ, Torres A, Gonzalez DA, Vives M, Ferrando C, Baeza J. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Rev Esp Anestesiol Reanim. 2020;67(5):245-252.

  4. Schwartz A, Martinez-Sanchez G, de Lucia AM, Viana SM, Constanta AM. Complementary application of the ozonized saline solution in mild and severe patients with pneumonia COVID-19: A non-randomized pilot study. J Pharm Pharmacogn Res 2021;9(2):126–142.

  5. Sunnen GV. Ozone in medicine: overview and future directions. J Adv Med. 1988;1(3):159-174.

  6. Gavazza A, Marchegiani A, Rossi G, et al. Ozone Therapy as a Possible Option in COVID-19 Management. Front Public Health. 2020;8:417.

  7. Martinez-Sanchez G, Schwartz A, Donna VD. Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19. Antioxidants (Basel). 2020;9(5):389.

  8. Rowen RJ, Robins H. A Plausible “Penny” Costing Effective Treatment for Corona Virus - Ozone Therapy. J Infect Dis Epidemiol. 2020;6:113.

  9. Wang, Z., Zhang, A., Meng, W., Wang, T., Li, D., Liu, Z., Liu, H., 2018. Ozone protects the rat lung from ischemia-reperfusion injury by attenuating NLRP3-mediated inflammation, enhancing Nrf2 antioxidant activity and inhibiting apoptosis. Eur. J. Pharmacol. 2018;835:82-93. doi: 10.1016/j.ejphar.2018.07.059.

  10. Di Mauro R, Cantarella G, Bernardini R, et al. The Biochemical and Pharmacological Properties of Ozone: The Smell of Protection in Acute and Chronic Diseases. Int J Mol Sci. 2019;20(3):634.

  11. Spagnolo P, Balestro E, Aliberti S. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020;8(8):750-752. doi:10.1016/S2213-2600(20)30222-8.

  12. Grillo F, Barisione E, Ball L, Mastracci L, Fiocca R. Lung fibrosis: an undervalued finding in COVID-19 pathological series. Lancet Infect Dis. 2020;21(4):e72. doi:10.1016/S1473-3099(20)30582-X

  13. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv Wet al. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020;296(2):E32-E40.

  14. Cattel F, Giordano S, Bertiond C, Lupia T, Corcione S, Scaldaferri M, Angelone L, De Rosa FG. Ozone therapy in COVID-19: A narrative review. Virus Res. 2021;291:198207.

  15. Baeza-Noci J, Re L, Menendez, S. COVID19 and ozone therapy (ver 2.6) [Internet]. Brescia: WFOT; 2020 Apr 1 [cited 2021 Apr 10]. 5p. Available from: https://www.wfoot.org/wp-content/uploads/2020/04/OTCoV22F.pdf

  16. Zheng Z, Dong M, Hu K. A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19. J Med Virol. 2020;92(11):2348-2350.

  17. Hernandez A, Viñals M, Pablos A, et al. Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study. Int Immunopharmacol. 2021;90:107261. doi:10.1016/j.intimp.2020.107261.

  18. Izadi M, Cegolon L, Javanbakht M, et al. Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review. Int Immunopharmacol. 2021;92:107307. doi:10.1016/j.intimp.2020.107307.

  19. Tascini C, Sermann G, Pagotto A, Sozio E, De Carlo C, Giacinta A, Sbrana F, Ripoli A, Castaldo N, Merelli M, Cadeo B, Macor C, De Monte A. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience. Intern Emerg Med. 2020:1-7.


Refbacks

  • There are currently no refbacks.